
Ascribe Bioscience: Developing eco-friendly products to boost crop defenses against pathogens since 2017.
Ascribe Bioscience, founded in 2017, is dedicated to developing eco-friendly crop protection solutions that empower farmers to combat pathogens without harming the environment. Headquartered in Ithaca, New York, the company focuses on creating seed treatment products that enhance crops' natural defenses using naturally-occurring small molecules from the soil microbiome. Their biobased products are designed to be shelf-stable and reliable under diverse field conditions, offering a sustainable alternative to traditional chemical treatments.
Notable figures associated with Ascribe Bioscience include its founding team of scientists and agricultural experts committed to sustainable farming practices. The company has garnered attention and support from investors focused on environmental sustainability and agricultural innovation. Key achievements include the successful development and field testing of their flagship seed treatment product, which has shown promise in increasing crop yield and resilience. Overall, Ascribe Bioscience is making a significant impact by providing farmers with effective, environmentally friendly tools to protect their crops and promote sustainable agriculture.
Companies similar to Ascribe Bioscience include AgBiome, Ascus Biosciences, Adaptive Symbiotic Technologies and Agrynex.
Ascribe Bioscience was founded in 2017.
Ascribe Bioscience's headquarters is located in Ithaca, NY, US.
Ascribe Bioscience's most recent funding round was for $3.2M (USD) in August 2022.
As of Aug 3, 2022, Ascribe Bioscience has raised a total of $7.2M (USD).
Ascribe Bioscience has 8 employees as of Feb 5, 2024.
Adaptive Symbiotic Technologies